Search

everythinglearnresearchcommunity

for

Search:↓

BMD-1141 effectively regrows hair in alopecia areata with less frequent dosing than current treatments.

Parthenolide promotes hair growth in mice and may influence pathways related to male pattern baldness.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

Finasteride doesn't affect bone density in male rats.

Finasteride doesn't affect bone density in male rats.

A high dietary antioxidant index may lower the risk of various diseases, but more research is needed.

The Rotterdam Study updated findings on elderly health, focusing on heart disease, genetics, lifestyle effects, and disease understanding.

Finasteride effectively treats male pattern baldness, improving hair growth and density.

5α-Reductase inhibitors do not consistently increase testosterone levels in the blood.

A man with hypoparathyroidism had other health issues that led to a diagnosis of a rare autoimmune disorder, APS-1.

Nanotechnology shows promise for better drug delivery and cancer treatment.

New treatments for hair loss show promise, but more research is needed to confirm their safety and effectiveness.

Adipose-derived stem cells are promising for regenerative medicine due to their accessibility, versatility, and low risk of immune rejection.

A very-low-calorie diet led to more weight loss and health improvements in obese women with PCOS than a moderate energy deficit diet.

Activating Tgr5 may help treat hair loss and bone loss.

Certain ESR1 gene variations may affect hormone levels and fat distribution in women with high male hormone levels.

Testosterone therapy increases bone density in older men with low testosterone levels.

Testosterone treatment effectively causes male physical development in transgender male adolescents but may lead to side effects like acne, higher BMI and blood pressure, lower good cholesterol, and decreased bone density.

Taking spironolactone and linestrenol for androgen excess can lead to lower bone density in young women.

A single injection of PTH–CBD can increase bone density for up to a year.

Women with hyperandrogenic amenorrhea have similar bone density to healthy women but lower than androgenized women without amenorrhea, and high DHEAS levels might affect bone density.

Patients treated with long-term intralesional corticosteroids for alopecia areata should be monitored for bone density changes and advised on osteoporosis prevention.

Balding men had lower bone density, while balding women had higher hip bone density.

Women with PCOS have similar bone density to healthy women, but those who are obese have higher bone density at some body sites.

Two siblings with a genetic mutation had a form of rickets that doesn't respond to vitamin D.

Women with early-onset baldness should be checked for early bone loss, but bone density doesn't change with baldness severity.

The skin's basement membrane has specialized structures and molecules for different tissue interactions, important for hair growth and attachment.

High hair calcium levels are linked to low calcium intake and low bone density.

Wedelolactone may help reduce bone loss with fewer side effects.

Diagnosing osteoporosis in transgender people is challenging due to unclear guidelines and hormone treatment effects.